Eric M. Reiman on Roche Pulls Plug on Two Phase 3 Trials of Crenezumab
COMMENT We are disappointed with today’s announcement about crenezumab and the discontinuation of CREAD 1 and CREAD 2 Phase 3 studies. We look forward to reviewing the findings when they are available. However, we are pleased to report that the Alzheimer’s Preven